Novartis Investigative Site is a clinical research site located in Fort Collins, Colorado, United States 80528.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 13 clinical trials.
Therapeutic areas: Chronic Obstructive Pulmonary Disease (COPD), Chronic Obstructive Pulmonary Disease, Relapsing Multiple Scelrosis.
Sponsors: Novartis Pharmaceuticals, Novartis, pharmaand GmbH.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 13 clinical trials on record. Their work covers Chronic Obstructive Pulmonary Disease (COPD), Chronic Obstructive Pulmonary Disease, Relapsing Multiple Scelrosis.
Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.